These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6185847)
1. Controlling the fetal globin switch in man. Orkin SH Nature; 1983 Jan; 301(5896):108-9. PubMed ID: 6185847 [No Abstract] [Full Text] [Related]
2. Induction of hemoglobin F synthesis in patients with beta thalassemia. Ley TJ; Nienhuis AW Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia? Fathallah H; Sutton M; Atweh GF Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670 [TBL] [Abstract][Full Text] [Related]
5. Gene switching -- a new therapeutic epoch: discussion paper. Nalbandian RM; Cypress GC J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499 [No Abstract] [Full Text] [Related]
6. Altering gene expression with 5-azacytidine. Jones PA Cell; 1985 Mar; 40(3):485-6. PubMed ID: 2578884 [No Abstract] [Full Text] [Related]
7. [Pharmacological correction of genetic defects - azacytidine in the treatment of thalassemia]. Kuratowska Z Pol Tyg Lek; 1983 Jun; 38(24):713-5. PubMed ID: 6196764 [No Abstract] [Full Text] [Related]
9. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea. Dover GJ; Charache S; Nora R; Boyer SH Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873 [No Abstract] [Full Text] [Related]
10. [Fetal hemoglobin]. Rokicka-Piotrowicz M Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927 [TBL] [Abstract][Full Text] [Related]
12. Induction of fetal hemoglobin in the treatment of sickle cell disease. Fathallah H; Atweh GF Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia. Platt OS Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231 [TBL] [Abstract][Full Text] [Related]
14. The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia. DeSimone J Semin Hematol; 2004 Oct; 41(4 Suppl 6):1-3. PubMed ID: 15799099 [No Abstract] [Full Text] [Related]
15. Fetal hemoglobin genes turned on in adults. Kolata G Science; 1982 Dec; 218(4579):1295-6. PubMed ID: 6183747 [No Abstract] [Full Text] [Related]
16. Chemotherapy and hemoglobin F synthesis in sickle cell disease. Dover GJ; Charache S Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061 [No Abstract] [Full Text] [Related]
17. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies. Stamatoyannopoulos JA; Nienhuis AW Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600 [TBL] [Abstract][Full Text] [Related]
18. The role of fetal hemoglobin-enhancing agents in thalassemia. Lal A; Vichinsky E Semin Hematol; 2004 Oct; 41(4 Suppl 6):17-22. PubMed ID: 15534853 [TBL] [Abstract][Full Text] [Related]
19. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443 [TBL] [Abstract][Full Text] [Related]
20. Regulation of gamma-globin expression in hereditary persistence of fetal hemoglobin. Ottolenghi S; Nicolis S; Bertini C; Ronchi A; Crotta S; Giglioni B Ann N Y Acad Sci; 1990; 612():191-5. PubMed ID: 1705408 [No Abstract] [Full Text] [Related] [Next] [New Search]